DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 128 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $99 | +73.7% | 2,792 | +39.9% | 0.00% | – |
Q1 2024 | $57 | -3.4% | 1,996 | -55.2% | 0.00% | – |
Q4 2023 | $59 | +51.3% | 4,460 | +3.7% | 0.00% | – |
Q3 2023 | $39 | -18.8% | 4,299 | 0.0% | 0.00% | – |
Q2 2023 | $48 | +29.7% | 4,299 | +34.0% | 0.00% | – |
Q1 2023 | $37 | -19.6% | 3,208 | -18.6% | 0.00% | – |
Q4 2022 | $46 | -99.9% | 3,943 | 0.0% | 0.00% | – |
Q3 2022 | $50,000 | +85.2% | 3,943 | 0.0% | 0.00% | – |
Q2 2022 | $27,000 | -22.9% | 3,943 | +8.6% | 0.00% | – |
Q1 2022 | $35,000 | – | 3,631 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |